Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesvirus, and calicivirus vaccine

Feline Practice

Volumn 25, Issue 4, 1997, Pages 12-19

  Scott, F W ^a   Geissinger, C ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21744448645     PISSN: 10576614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Anonymous. Compendium of Veterinary Products, ed 3. North American Compendiums, Inc. Port Huron, MI. Ed by K Bennet. 1995, p 488.
2. Scott FW, Csiza CK, Gillespie JH: Feline Viruses. Serum-Neutralization Test for Feline Panleukopenia. Cornell Vet 60:183-191, 1970.
3. Bittle JL, Emrich SA, Gauker FB: Safety and Efficacy of an Inactivated Tissue Culture Vaccine for Feline Panleukopenia. JAVMA 157:2052-2056, 1970.
4. Anonymous. Code of Federal Regulations. Title 9: Animals and Animal Products. Federal Register 38:8426. US Government, Washington, DC, 1973.
5. King DA, Croghan DL: Immunoflourescence of Feline Panleukopenia Virus in Cell Culture: Determination of Immunological Status of Felines by Serum Neutralization. Can J Comp 29:85-89, 1965.
6. Povey RC, Koones H, Hays MB: Immunogenicity and Safety of an Inactivated Vaccine for the Prevention of Rhinotracheitis, Caliciviral Disease, and Panleukopenia in Cats. JAVMA 177:347-350, 1980.
7. Scott FW, Csiza CK, Gillespie JH: Maternally Derived Immunity to Feline Panleukopenia. JAVMA 156:439-453, 1970.
8. Bittle JL, Rubic WJ: Immunogenic and Protective Effects of the F-2 Strain of Feline Viral Rhinotracheitis Virus. Am J Vet Res 36:89-91, 1975.
9. Scott FW: Evaluation of a Feline Viral Rhinotracheitis Vaccine. Feline Pract 5(1):17-22, 1975.
10. Scott FW: Evaluation of a Feline Virual Rhinotracheitis-Feline Calicivirus Disease Vaccine. Am J Vet Res 38:229-234, 1977.
11. Walton TE, Gillespie JH: Feline Viruses. VII. Immunity to the Feline Herpesvirus in Kittens Inoculated Experimentally by the Aerosol Method. Cornell Vet 60:232-239, 1970.
12. Bittle JL, Rubic WJ: Immunization Against Feline Calicivirus Infection. Am J Vet Res 37:275-278, 1976.
13. Smith CAD, Macy DW, Carmichael LE, et al: Are We Vaccinating Too Much? JAVMA 207:421-425, 1995.
14. Christenson B, Bottiger M: Measles Antibody: Comparison of Long-Term Vaccination Titres, Early Vaccination Titres and Naturally Acquired Immunity to and Booster Effects on the Measles Virus. Vaccine 12:129-133, 1994.
15. Davidkin I, Valle M, Julkunen I: Persistence of Anti-Mumps Virus Antibodies After a Two Dose MMR Vaccination. A Nine-Year Follow-Up. Vaccine 13:1617-1622, 1995.
16. Szilagyi PG, Rodewald LE, Humiston SG, et al: Immunization Practices of Pediatricians and Family Physicians in the United States. Pediatrics 94:517-523, 1994.
17. Watson JC, Pearson JA, Markowitz LE, et al: An Evaluation of Measles Revaccination Among School-Entry-Aged Children. Pediatrics. 97:613-618, 1996.
18. Anonymous. CDC. Measles Prevention. Recommendations of Immunization. Practices Advisory Committee (ACIP). MMWR 38:1-18, 1989.
19. Ukkonen P: Rubella Immunity and Morbidity: Impact of Different Vaccination Programs in Finland 1979-1992. Scand J. Infect Dis 28:31-35, 1996.